About CRESTONE, INC.
Crestone, Inc. is a Boulder, Colorado-based clinical stage biopharmaceutical company focused on developing novel mechanism of action small molecule drugs for serious bacterial infections, including C. difficile, MRSA, and tuberculosis.
Development of novel mechanism of action small molecule drugsResearch in antibacterial agents for serious infectionsPipeline programs targeting C. diff, MRSA, and tuberculosis
Recent Federal Awards
| Award | Agency | Amount | Date |
|---|---|---|---|
| TO MAKE AN AWARD UNDER HHS-NIH-NIAID-BAA2018 | Department of Health and Human Services | $33.3M | |
| SYNTHESIS AND TESTING OF NOVEL ANTIBIOTIC CHEMICAL COMPOUNDS FOR ROCKY MOUNTAIN REGIONAL VA MEDICAL CENTER RES | Department of Veterans Affairs | $102K | |
| SYNTHESIS AND TESTING LABORATORY SERVICES FOR RESEARCH | Department of Veterans Affairs | $99K | |
| TO ADVANCE A PROMISING, SMALL-MOLECULE COMPOUND CRS0540 TO IND FILING AND THROUGH PHASE I CLINICAL STUDIES. | Department of Health and Human Services | $22.0M |
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to CRESTONE, INC. right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.